loader image
Friday, January 9, 2026
75.6 F
McAllen
- Advertisement -

Driscoll one of 40 hospitals nationwide participating in Pfizer trial for COVID-19 vaccine for children younger than 12

Translate to Spanish or other 102 languages!

Iris Gutierrez (from left), Sophia Gutierrez, 10, Pediatrician Valeria Munguia Jovel, MD, Erin Richmond, MS, RN, CCRP, Program Manager, Global Institute for Hispanic Health, and Jaime Fergie, MD, Director of Infectious Diseases at Driscoll Children’s Hospital and Medical Director of Driscoll’s and Texas A&M University’s Global Institute for Hispanic Health.

Mega Doctor News

- Advertisement -

CORPUS CHRISTI – Driscoll Children’s Hospital is one of 40 hospitals nationwide and 100 hospitals worldwide participating in a Pfizer clinical trial for a COVID-19 vaccine for children younger than 12. Driscoll is the only clinical trial site for South Texas.

The first participant, Sophia Gutierrez, 10, of Odem, was at Driscoll on Monday undergoing the necessary labwork and receiving her first shot.

“I really wanted to get vaccinated so I could see my grandmother and other family members,” said Sophia.

- Advertisement -

The clinical trial is open for children six months to 11 years. Driscoll Children’s Hospital and Texas A&M University’s Global Institute for Hispanic Heath are conducting the trial, but participants do not have to be Hispanic or Driscoll patients.

“The Global Institute for Hispanic Health strives to bring important clinical studies to our region. We are happy to be able to offer this COVID-19 trial to the children of South Texas,” said Jaime Fergie, MD, Director of Infectious Diseases at Driscoll Children’s Hospital and Medical Director of Driscoll’s and Texas A&M University’s Global Institute for Hispanic Health.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Study Shows a Sharp Drop in Teen Wellness Visits During Transition to Adulthood

It’s common that as kids get to high school and transition to adulthood, they begin to skip yearly wellness visits with a pediatrician or other primary care provider.

Wegovy® Pill, First Oral GLP‑1 for Weight Loss, Now Available Nationwide

Wegovy® pill is now available, providing those seeking help with their weight the revolutionary science of GLP-1 medicine in a pill for the first time.

Historic Reset of U.S. Nutrition Policy with New Food Pyramid

Mega Doctor News WASHINGTON, D.C. – U.S. Department of Health and Human Services...

Metabolic Trigger Identified That Shuts Down Key Tumor‑Fighting Gene

A novel tumor suppressor, BATF2, can be silenced by factors in the tumor microenvironment, leading to a reduced immune response in five preclinical models of head and neck cancer, according to researchers from The University of Texas MD Anderson Cancer Center. 
- Advertisement -
×